Barely Significant
← all excerpts

The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma.

Oncotarget · 2017 · PMC5354886 · PMID 27999211

Europe PMCDOI
1
hedged sentence
0.0920
closest p · 1.8× alpha
0.0920
boldest claim

The sentences

borderline significanceP = 0.092so close (0.05 < p ≤ 0.1)
Furthermore, univariate analysis revealed a favorable PFS for patients with longer TKI-free interval (hazard ratio [HR] 0.48, 95% CI 0.24–0.98, P = 0.044) and a prolonged OS for those with good ECOG performance status (PS) (HR 0.34, 95% CI 0.19–0.61, P < 0.001), and that patients with insertion chemotherapy tended to exhibit better efficacy although only a borderline significance was observed (HR 0.60, 95% CI 0.34–1.09, P = 0.092) (Table 3 ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.